Overview
Accelerates medical innovation through capital and capabilities.
Founded
2017
Deals ยท 12mo
1
Stage focus
Geographic focus
Sector focus
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
UroMems | May 2026Led | $60 MOther Equity | |
Treeline Biosciences | Sep 2025Participated | $200 MSeries A | |
XII Medical | Aug 2024Participated | $45 MSeries B | |
Lumen Energy | Jun 2023Participated | $11 MSeries A | |
Cortica | Apr 2023Participated | $75 MOther Equity | |
Puzzle Medical Devices | Feb 2023Participated | $25 MSeries A | |
XII Medical | May 2022Led | $30 MSeries A | |
Third Harmonic Bio | Feb 2022Participated | $105 MSeries B | |
AcuityMD | May 2021Participated | $7 MOther Equity | |
Atriomx | Dec 2020Led | $10 MSeries A | |
Protaryx Medical | Jun 2020Led | $8 MSeries A | |
Verix Health | Oct 2019Led | $8 MSeries A | |
UroMems | May 2026Led | $60 MOther Equity | |
Treeline Biosciences | Sep 2025Participated | $200 MSeries A | |
XII Medical | Aug 2024Participated | $45 MSeries B | |
Lumen Energy | Jun 2023Participated | $11 MSeries A | |
Cortica | Apr 2023Participated | $75 MOther Equity | |
Puzzle Medical Devices | Feb 2023Participated | $25 MSeries A | |
XII Medical | May 2022Led | $30 MSeries A | |
Third Harmonic Bio | Feb 2022Participated | $105 MSeries B | |
AcuityMD | May 2021Participated | $7 MOther Equity | |
Atriomx | Dec 2020Led | $10 MSeries A | |
Protaryx Medical | Jun 2020Led | $8 MSeries A | |
Verix Health | Oct 2019Led | $8 MSeries A |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Series A | 6 | 3 |
| Series B | 0 | 2 |
| Other Equity | 1 | 2 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Apr '19 | 1 |
| May '19 | 0 |
| Jun '19 | 0 |
| Jul '19 | 0 |
| Aug '19 | 0 |
| Sep '19 | 0 |
| Oct '19 | 2 |
| Nov '19 | 0 |
| Dec '19 | 0 |
| Jan '20 | 0 |
| Feb '20 | 0 |
| Mar '20 | 0 |
| Apr '20 | 0 |
| May '20 | 0 |
| Jun '20 | 1 |
| Jul '20 | 0 |
| Aug '20 | 0 |
| Sep '20 | 0 |
| Oct '20 | 0 |
| Nov '20 | 0 |
| Dec '20 | 1 |
| Jan '21 | 0 |
| Feb '21 | 0 |
| Mar '21 | 0 |
| Apr '21 | 0 |
| May '21 | 1 |
| Jun '21 | 0 |
| Jul '21 | 0 |
| Aug '21 | 0 |
| Sep '21 | 0 |
| Oct '21 | 0 |
| Nov '21 | 0 |
| Dec '21 | 0 |
| Jan '22 | 0 |
| Feb '22 | 1 |
| Mar '22 | 0 |
| Apr '22 | 0 |
| May '22 | 1 |
| Jun '22 | 0 |
| Jul '22 | 0 |
| Aug '22 | 0 |
| Sep '22 | 0 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 1 |
| Mar '23 | 0 |
| Apr '23 | 1 |
| May '23 | 0 |
| Jun '23 | 1 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 0 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 0 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 1 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 1 |
| Oct '25 | 0 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 0 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 1 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 12 |
| Manufacturing | 1 |
| AI & Machine Learning | 1 |
| Clean Energy & Sustainability | 1 |
| Data, Analytics & IT | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 0 |
| $5M-$10M | 3 |
| $10M-$25M | 3 |
| $25M-$50M | 4 |
| $50M-$100M | 2 |
| $100M-$250M | 2 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 3 of 3 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 11 |
| Europe | 2 |
| Canada | 1 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Aperture Venture Partners | 4 |
| Cleveland Clinic | 2 |
| JobsOhio | 2 |
| KKR | 2 |
| Longview Ventures | 2 |
| OrbiMed | 2 |
| RA Capital Management | 2 |
| .406 Ventures | 1 |
| AI Life Sciences | 1 |
| Aisling Capital | 1 |
| ARCH Venture Partners | 1 |
| Atlas Venture | 1 |
| Autism Impact Fund | 1 |
| BDC Capital | 1 |
| Benchmark Capital | 1 |
| Boxer Capital | 1 |
| Bridge Investment Group | 1 |
| Broadview Ventures | 1 |
| BVF Partners | 1 |
| Casdin Capital | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 7 | 50% |
| Participating | 7 | 50% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 5 | 71% |
| Co-led | 2 | 29% |
Team
Chief Medical Officer, Managing Director
Business Management
Chief Financial Officer
Founder, CEO & Chairman